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1 
Abstract 
 
Concern over the safety of BPA in plastic products has lead to its substitution with related 
bisphenols BPF and BPS, though the safety of these alternatives is unknown. Using fluorescence 
microscopy and Western blots, we examined cellular stress responses in several human cell lines 
following treatment with bisphenols. We find that BPA and BPF cause stress granule formation, 
likely via activation of the PKR kinase pathway. This work has important implications for the 
continued use of bisphenols in plastics. 
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4 
Background 
 
Cellular Stress Response 
As eukaryotic cells live and grow, they encounter many different environmental stresses 
to which they must adapt, or at least temporarily endure, in order to survive. Some common 
stressors include thermal stress, oxidative stress,  viral infection, and heavy metal stress, among 
others (Kültz 2003). As a response mechanism to such a wide variety of potential stresses, 
eukaryotic cells have developed the cellular stress response (CSR). The CSR encompasses the 
cellular processes that occur when a cell’s macromolecules are damaged to a significant level 
(Kültz 2003). During this response, various cellular pathways are triggered that collectively work 
to evaluate, prevent, and reverse damage to the cell, and temporarily increase the cell’s ability to 
tolerate stress (Kültz 2003; Kültz 2005). If damage to the cell is too severe to repair, the CSR 
will induce the cell to undergo apoptosis (Kültz 2003). Different portions of the CSR act over 
different time frames. Short-term responses are fast and focus on managing damaged 
macromolecules (Kültz 2003). The long-term CSR is much slower and is focused on restoration 
of cellular homeostasis (Kültz 2003; Kültz 2005). During the initial stage of the CSR, cell 
growth is arrested, nucleic acids and salvageable proteins are repaired, and any macromolecular 
debris is cleared (Kültz 2003). This stage of the response is stress-specific and involves the 
formation of stress granules and processing bodies (Kültz 2005). 
 
Stress Granules 
Stress granules (SGs) are transient structures that form inside cells during a cellular stress 
response that may be caused by a wide variety of stressors including infection, toxicity, and 
nutrient deficiency (Donnelly et al. 2013). They contain the mRNAs from stress-induced 
translational arrest as well as certain proteins associated with stress response, some of which are 
common to all SGs such as G3BP and TIA-1, and some which depend on the mechanism of 
stress induction. The mRNAs stalled from translation are released from the polysomes, and are 
packed into cytoplasmic foci to form the SGs (Aulas et al. 2017). The translation-related proteins 
from the disassembled polysomes are sorted, and some are also packed into the SGs (Kedersha et 
al. 2008). These polysomes, i.e. messenger ribonucleoprotein particles (mRNPs) are reorganized 
before packed into SGs (Kedersha et al. 2013). 
One common SG formation mechanism is via phosphorylation of eukaryotic translation 
initiation factor 2α (eIF2α). Under normal conditions, eIF2α is responsible for the delivery of 
initiator tRNAs to pre-initiation complexes required for mRNA translation. During a stress 
response, certain kinases are activated and phosphorylate eIF2α at serine 51 (S51) position, thus 
preventing translation initiation (Aulas et al. 2017). This results in a number of untranslated 
mRNAs accumulating in the cell, which then become components of the stress granules. There 
are four known kinases that can perform this phosphorylation event in mammals, including 
protein kinase R (PKR), general control non-repressed 2 kinase (GCN2), heme-regulated 
inhibitor kinase (HRI), and PKR-like ER kinase (PERK) (Basu et al. 2017). These kinases have 
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been associated with responses to viral infection, nutrient deprivation, heme deficiency, and 
endoplasmic reticulum stress, respectively (Basu et al. 2017). 
 
Processing Bodies 
Processing bodies (P bodies, or PBs) are also self-assembled cellular structures formed in 
response to stress. They are related to the SGs and share some similarities, but also have several 
distinct characteristics. PBs contain several factors involved in mRNA decay, while SGs recruit 
translation initiation factors (Kedersha et al. 2008). PBs and SGs can interact with each other 
when, for example, certain mRNA transcripts in SGs may be transported to PBs for degradation 
(Kedersha et al. 2008). 
 
Bisphenol A 
Cell responses can be activated by a number of stressors; heat shock, viral infection, 
oxidative stress, and toxins all initiate a cell stress response. Bisphenol A (2,2-bis (4-
hydroxyphenyl) propane, commonly known as BPA) is a pervasive chemical compound that 
causes damage to DNA (Meeker et al. 2010). BPA is a synthetic organic compound composed of 
a pair of connected phenol rings. Initially discovered in 1890, it was not widely used in plastic 
manufacture until the 1960’s. It is a major component in the manufacture of epoxy resins and 
polycarbonate plastics, as well as less common polyacrylates and polyesters. Epoxy resins are 
used widely in automotive parts, PVC piping, can coatings, adhesives, and dental sealants while 
polycarbonate plastics are found in household appliances, food packaging, bottles, plastic wraps, 
packages, and utensils (Kang et al. 2006).  
Currently over 6 billion pounds of BPA are produced per year worldwide, with an 
additional 100 tons released into the atmosphere as a byproduct of the production process. BPA 
has one of the highest volumes of production of any chemical manufactured today (Vandenberg 
et al. 2007). It can be detected in most available environmental sources, including groundwater, 
river water, the atmosphere, and soil (Kang et al. 2006). Despite its environmental prevalence, 
most BPA intake is still a result of plastic leaching from food packaging into the food it contains. 
BPA that enters the human system is generally metabolized to BPA glucuronide (BPA-g) by the 
liver, then removed in urine (Lacroix et al. 2011). The BPA that is not metabolized and excreted 
can be detected in human serum, amniotic fluid, follicular fluid, placental tissue, and umbilical 
cord blood. BPA is so prevalent that it has been shown to be detected in upwards of 90% of urine 
samples in a variety of sample populations from different ages, genders, and geographic regions 
(Vandenberg et al. 2007).  
BPA that is not excreted from the human system functions as a toxin in many pathways, 
and has been linked to a number of chronic diseases including diabetes, obesity, cardiovascular 
disease, chronic kidney disease, birth defects, developmental disorders, respiratory diseases, 
behavior disorders, autoimmune diseases, and breast cancer. BPA is linked to many diseases, but 
operates in them all through five mechanisms; endocrine disruption, genetic damage, epigenetic 
effects, oxidative stress, and cell signaling (Rezg et al. 2014). 
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Endocrine disruptors chemically interfere with the natural hormone signaling system by 
altering the secretion of hormones, interfering with hormone-receptor interaction, or modifying 
the metabolism of circulating hormones (Rezg et al. 2014). BPA was first identified as an 
endocrine disruptor in the 1930’s during a search for a synthetic estrogen alternative. Inside the 
cell, BPA mimics the function of estrogen, binding to estrogen receptors alpha and beta (with a 
particular affinity for ERβ) and interfering with the normal hormone-receptor interaction 
(Routledge et al. 2000). Estrogen receptors regulate cell proliferation and cell stress response 
pathways - their overstimulation can lead to diverse effects in the organs that estrogen targets 
such as the brain, ovaries, mammary glands, and uterus (Vandenberg et al. 2009). 
Genetic damages can be caused by DNA damage or chromosomal aberrations 
(aneuploidy, chromosomal segmentation). In vitro and in vivo studies have shown BPA to 
induce DNA adducts, aneuploidy, and mutagenicity, which contribute to infertility (in both 
sexes), miscarriages, and birth defects (Rezg et al. 2014). Additionally, genetic damage activates 
the cell stress response. 
Epigenetic effects on the cell involve mechanisms of gene regulation that produce 
changes in gene expression without changing the genetic code. This is achieved through DNA 
methylation, histone modification, and expression of ncRNAs. BPA alters pathways by two of 
these mechanisms, mainly methylation and ncRNAs. Specifically, it has been shown to cause 
hypermethylation of estrogen receptors, hypomethylation of CpG (cytosine-guanine 
dinucleotide) islands in DNA, hypermethylation of CpG islands in genes of membrane proteins, 
and alter microRNA expression (Rezg et al. 2014). 
Oxidative stress is caused by increased production of reactive oxygen species, or a 
decrease in antioxidant defense abilities. BPA has been shown to disturb oxidative homeostasis 
through mitochondrial function, modification of antioxidant enzymes, and increasing available 
acid reactive substances (products of degradation of unstable lipid peroxidases) (Rezg et al. 
2014). Additionally, oxidative stress is a known activator of the cellular stress response (Kültz 
2003). 
Cell signaling to induce apoptosis is the final mechanism by which BPA affects the cell. 
BPA increases intracellular calcium levels and phosphorylation of kinases and nuclear 
translocation factors involved in apoptosis. Hormone interference also occurs at the signaling 
level; BPA activates kinases that disrupt hormonal mechanisms such as cellular response to 
estrogen (Rezg et al. 2014). 
 
Other Bisphenols 
Given the large body of work supporting the damaging effects of bisphenol A, some 
plastics manufacturers have adopted different bisphenols as the main component in plastics. 
These plastic products are marketed as “BPA free”, though they instead contain only slightly 
variated bisphenols that are structural analogues of BPA, such as BPS or BPF. Both BPS and 
BPF have been increasingly found in a variety of personal care products, paper products, and 
food, and have been detected in samples from several different environmental sources (Rochester 
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& Bolden, 2015). Furthermore, these compounds have been detected in urine samples at levels 
comparable to BPA (Rochester & Bolden, 2015). One study that analyzed the presence of BPS in 
urine samples from 8 countries including the U.S. found that 81% of the samples contained BPS 
(Liao et al. 2012). These findings indicate that the substitution of BPA for BPF and BPS has led 
to increased concentrations and frequencies of the substitute compounds in both the environment 
and in the general population. 
Despite their increasing use as BPA alternatives use due to health concerns, neither BPS 
nor BPF have been shown to be safer alternatives to BPA (Eladek et al. 2015). There is currently 
little information available about the effects of BPA substitutes on health; however, since these 
compounds are structural analogues, they also have the potential to have similar effects as BPA 
on biological systems (Rosenmai et al. 2014). For instance, studies that have examined the 
hormonal activities of BPF and BPS have found that they may have endocrine-disrupting effects 
that are similar to BPA (Rochester & Bolden 2015; Eladak et al. 2015).  
Research on the effects of BPA, BPF, and BPS on stress granule formation previously 
have used a GFP-tagged G3BP protein as a marker, because of its presence in nearly all SG’s. 
Research has shown that both BPA and BPF cause significant stress granule formation at acute 
high dose exposure (Salerno et al. 2016). BPS was not found to cause significant stress granule 
formation, even at high doses (Salerno et al. 2016). The specific mechanisms for these responses 
and the phosphorylation state of eIF2α in response to BPF and BPS are unclear, and it is 
unknown what specific stressors these compounds mimic.  
Our project aimed to determine eIF2α phosphorylation state in response to treatment with 
BPA, BPF, and BPS, and to determine the specific eIF2α kinase(s) responsible for stress granule 
induction in response to treatment with each bisphenol. We hypothesized that stress granule 
formation in response to bisphenols (BPA, BPF, and BPS) is the result of a phosphorylation of 
the eIF2α translation initiation factor, and that at least one of the four eIF2α kinases is involved 
in this pathway. Additionally, as bisphenols have been shown to have estrogen-like effects, we 
predicted that cell lines containing estrogen receptors may respond differently to treatment with 
the bisphenols than cell lines that do not contain estrogen receptors. 
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Materials and Methods 
 
Cell Line Maintenance 
Double-stable osteosarcoma (U2OS-DS) cells containing GFP-G3BP and RFP-DCP1 (Kedersha 
et al. 2008), T47D breast cancer cells, and various chronic myelogenous leukemia-derived HAP1 
cell lines (Aulas et al. 2017) were maintained. Complete DMEM media (DMEM with 10% FBS, 
1% Penicillin/Streptomycin and 1% glutamine) was used for the U2OS-DS and HAP1 lines, 
while complete DMEM with 1% insulin was used for the T47D cells. Cells were incubated at 
37°C with 5% CO2 and sub-cultured approximately every other day at a ratio of 1:4 or 1:6 
(U2OS-DS), 1:3 or 1:4 (T47D), or 1:10 (HAP1). 
 
Acute Exposure Assays 
U2OS-DS, T47D, or HAP1 cells were plated in a 12-well plate with coverslips at 8 x 104 - 1.2 x 
105 cells/well.  Each well contained 1 mL media. The plate was incubated for ~48 hours at 37˚C. 
See Figure 1 below for the plate arrangements used. 0.5 mL media was taken from each of the 
wells and combined with media from other wells that received the same treatment or contained 
the same cell line. Media was either mixed with methanol, sodium arsenite, BPA, BPF, or BPS 
to a final concentration of 500 µM, or left untreated. The remaining media was aspirated from 
each well, 0.45 mL of the treated media was returned to the appropriate wells, and the plate was 
incubated at 37˚C for 1 hour. 
 
(a) (b)  
(c)  
 
Figure 1: Acute exposure assay plate arrangement used for (a) U2OS-DS cells, (b) U2OS-DS 
and T47D cells, and (C) HAP1 cell lines 
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Media was aspirated after incubation, and the wells were rinsed with non-sterile 1X PBS. About 
0.5 mL 4% paraformaldehyde was added to each well, and the plate was incubated at room 
temperature on an orbital shaker for 10 minutes. The wells were then incubated with cold 100% 
methanol for 10 minutes, followed by two rinses with 1X PBS. Following the rinses, U2OS-DS 
cells were directly mounted, while T47D and HAP1 cells were first stained (see staining 
procedure below). Following any necessary staining, the coverslips were mounted onto glass 
slides (one coverslip per slide) with vinyl mounting media (Fukui et al. 1987). The percentage of 
cells positive for stress granules was calculated based on manual counts using fluorescence 
microscopy. The cells were viewed at 400X - 630X magnification, and a minimum of 250 cells 
over 4 fields were counted on each slide. To reduce bias, the labels on the slides were blinded, 
and the results from three independent counts were averaged.  
 
Staining Cells for Fluorescence Microscopy 
Following the acute exposure assay and fixing of the cells with paraformaldehyde, each well was 
treated with 0.5 mL of a 5% NHS (normal horse serum) in PBS blocking solution, and the plate 
was incubated on a rotator for 1 hour. The blocking solution was removed from the wells, 0.5mL 
of the primary antibody solution (Table 1) was added to each well, and the plate was incubated 
on a rotator for 1 hour. The antibody was then removed and saved, and the wells were washed 
three times by addition of 1X PBS and incubation on a rotator for five minutes. The PBS was 
removed between washes and after the final wash. 0.5mL of the secondary antibody was then 
added to each well (Table 1). The secondary stain was applied for 1 hour while the plate was 
incubated on an orbital shaker. The secondary stain was then removed, and wells were washed 
three times with 1X PBS as before. The coverslips were then mounted as described above. 
 
Western Blot from acute exposure assay 
An acute exposure assay was performed on U2OS-DS cells with a plate arrangement as shown in 
Figure 1b. 
 
Sample Collection: 
Media was aspirated after 1 hour incubation with the treatments, and the wells were rinsed twice 
with 1X PBS, which was then aspirated fully. Each well was treated with 100 µL of 2X SDS 
sample buffer containing 10 mM DDT. The samples buffer were collected from each well into 
microcentrifuge tubes via scraping with a rubber policeman. Labelled samples were stored at -
80°F. 
 
Gel electrophoresis and Blotting: 
Frozen samples were heated at 80˚C for ~15 minutes. 10 µL of each sample was loaded into a 
polyacrylamide gel (4-20%, BioRad). The gel was run at 120 mV for about 45-50 minutes. The 
proteins were transferred to PVDF membrane via electro blotting at 80 mV for 80 minutes. The 
presence of transferred protein was visualized using Ponceau red stain. The membrane was 
10 
blocked in a solution of 5% dry milk and wash buffer (0.05% Tween-20 in 1X PBS) overnight. 
The membrane was treated with one of the two primary antibodies used (see Table 1)  and stored 
at 4˚C overnight. The membrane was then washed with wash buffer and treated with the 
secondary antibody (see Table 1) for 1 hour. One 5-minute rinse and three 10-minute rinses with 
wash buffer were carried out before 1 mL of each developing solution (from SuperSignal West 
Pico Trial Kit, Prod #34079) was added onto the membrane and allowed to develop for at least 2 
minutes. The blot was then imaged on a Bio Rad ChemiDoc XRS+ System and analyzed using 
Bio Rad Image Lab software. 
 
Table 1: Antibodies and Dilutions Used in this Study 
Antibody Application Dilution Manufacturer Product 
Number 
mouse-anti-G3BP Immunofluorescence 
primary stain 
2 µL/mL in 5% 
NHS/PBS 
Santa Cruz 
Biotechnology 
I0617 
anti-mouse IgG 
Alexa Fluor 488 
(green) stain 
Immunofluorescence 
secondary stain 
1 µL/mL in 5% 
NHS/PBS 
Cell Signaling 
Technology 
4408S 
Hoechst 33342 
(blue) nuclear stain 
Immunofluorescence 
secondary stain 
1 µL/mL in 5% 
NHS/PBS 
Life Technologies 1642791 
rabbit-anti-p-eIF2α Western Blot 
primary stain 
2 µL/mL in 5% 
dry milk in wash 
buffer 
Cell Signaling 
Technology 
3398T 
rabbit-anti-eIF2α Western Blot 
primary stain 
2 µL/mL in 5% 
dry milk in wash 
buffer 
Cell Signaling 
Technology 
5324T 
HRP-linked anti-
rabbit IgG 
Western Blot 
secondary stain 
2 µL/mL in 
wash buffer 
Cell Signaling 
Technology 
7074P2 
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Results 
 
BPA, BPF and BPS acute exposure comparison assay 
 An acute exposure assay was performed on U2OS-DS cells to determine the percentage 
of cells expressing stress granules in response to treatment with BPA, BPS, or BPF, with 
methanol treatment used as a negative control. As shown in Figure 2, when viewed under the 
fluorescence microscope, cells expressing stress granules appeared to contain many small, bright 
dots within their cytoplasm, while the cytoplasm of cells that did not contain stress granules 
appeared to be a more diffuse, consistent green. This visual difference was used to count and 
determine the percentage of cells that had formed stress granules in response to each of the 
treatments. 
 
 
Figure 2: U2OS-DS cells that (A) contain stress granules (B) do not contain stress granules 
 
The results of the acute exposure assay can be seen in Figure 3 below. It was found that 
99.3% of cells treated with BPA formed stress granules (the largest percentage of the three 
bisphenols). Cells responded more variably to BPF, in response to which 10.6% of the cells 
formed stress granules. Only 1.2% of cells treated with BPS formed stress granules, which was 
comparable to the negative control of 1.4%. These results were highly consistent with previously 
obtained data  (Salerno et al. 2016; Henry et al. 2015), indicating that the cells and reagents were 
performing in our hands as expected. BPA caused the highest levels of stress granule formation, 
followed by BPF. BPS resulted in the lowest percentage of cells expressing stress granules of the 
three bisphenols.  
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Figure 3: Stress granule formation in response to acute exposure of U2OS-DS cells to various 
bisphenols. Cells were treated with 500 µM solutions of the indicated bisphenols for 1 hour. 
(n=1) 
 
BPA, BPF BPS, arsenite, and methanol acute exposure comparison assay 
 As bisphenols such as BPA are known to have estrogenic effects and are capable of 
binding to estrogen receptors, it was hypothesized that cells containing the estrogen receptor may 
respond differently to treatment with bisphenols than those that do not express the ER, such as 
the U2OS-DS line. In order to test this, an acute exposure assay was performed on T47D cells, 
which express ERβ, to determine the percentage of cells expressing stress granules in response to 
treatment with BPA, BPS, or BPF. Methanol treatment and no added treatment were used as 
negative controls, and arsenite treatment was used as a positive control. As for the U2OS-DS 
cells, stress granules could be visualized as dots within the cytoplasm, allowing the number of 
cells expressing stress granules following each treatment to be counted and the percentages to be 
determined. Figure 4 shows a representation of the appearance of the cells under the fluorescent 
microscope following treatment and staining. 
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Figure 4: Composite images of T47D cells from green and blue channels on the fluorescence 
microscope, following a one hour treatment with (A) BPA, (B) BPF, (C) BPS, (D) arsenite, (E) 
methanol, and (F) negative control. Nuclei appear blue, while stress granule proteins (G3BP) are 
green. 
 
The results of the acute exposure assay can be seen in Figure 5 below. Both negative 
controls showed low percentages of stress granule formation (0.4% and 0.9%), while 98.9% of 
cells treated with arsenite formed stress granules. Among the bisphenols, it was again found that 
the BPA treatment showed the largest percentage of cells to form stress granules at 51.6%, while 
BPF and BPS followed at 31.4% and 0.6%, respectively. While 99.3% of the U2OS-DS cells 
formed stress granules after treatment with BPA, on average only 51.6% of the T47D cells 
formed stress granules following the same treatment. Although four separate trials of this assay 
were performed, the percentage of stress granules formed in each trial was highly variable in the 
BPA and BPF treatment conditions, as indicated by the large error bars. While the three 
bisphenols again produced a similar trend in the percentages of cells that they induced to form 
stress granules, where BPA caused the highest stress granule formation followed by BPF and 
then BPS, the percentages differed from those seen in the U2OS-DS cells, particularly as a much 
lower percentage of stress granule formation was seen after BPA treatment of the T47D cells. 
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Figure 5: Stress granule formation in response to acute exposure of T47D cells to bisphenols. 
Cells were treated with 500 µM solutions of the indicated bisphenols or arsenite for 1 hour. Error 
bars represent standard error. (n=4) 
 
Western Blot from acute exposure assay 
To determine the phosphorylation state of eIF2α  in response to each of the treatments, 
U2OS-DS cells were treated with bisphenols, and a series of Western blots were performed on 
the cell extracts. The results of the stain for total and phosphorylated eIF2α can be seen below in 
Figure 6. The black bands in the bottom row represent total eIF2α, and appear to have a 
consistent width across all lanes, indicating an equal protein load. The top row of Figure 6 shows 
the phosphorylated form of eIF2α. In this row, lanes 1-4 and 11-12 (the negative control and 
BPS lanes) show only faint bands, while lanes 5-8 (arsenite and BPA treatments) show dark 
bands. Lanes 9 and 10, corresponding to the BPF treatments, show bands of intermediate 
intensity. This indicates that BPA and arsenite cause high levels of eIF2α phosphorylation, BPF 
causes intermediate levels of eIF2α phosphorylation, and BPS causes levels of eIF2α 
phosphorylation that are only slightly elevated from the absence of phosphorylation seen in the 
negative controls. 
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Figure 6: Western blot of acute exposure assay U2OS-DS cell extracts, stained for 
phosphorylated eIF2α (top) and total eIF2α (bottom). Cells treated with: negative control (lanes 1 
and 2), methanol (lanes 3 and 4), arsenite (lanes 5 and 6), BPA (lanes 7 and 8), BPF (lanes 9 and 
10), and BPS (lanes 11 and 12). The blots shown were selected as blots produced from three 
biological replicates. 
 
BPA acute exposure comparison assay for HAP1 cells 
To determine which kinase was responsible for the eIF2α phosphorylation observed in 
response to BPA in the Western blot results, an acute exposure assay was performed on 6 HAP1 
cell lines. One line was WT cells (serving as a negative control), the second S51A line contains a 
mutation of the eIF2α phosphorylation site that prevents phosphorylation and thus stress granule 
formation (serving as a positive control), and the four remaining cell lines each contain a 
CRISPR knockout of one of the four kinases potentially responsible for eIF2α phosphorylation  
(Aulas et al. 2017). The cell line containing the eIF2α kinase that most strongly responds to BPA 
stress would be expected to exhibit a lower percentage of cells expressing stress granules in 
response to treatment with BPA.  
As for the U2OS-DS cells, stress granules could be visualized as dots within the 
cytoplasm, allowing the number of cells expressing stress granules following each treatment to 
be counted and the percentages to be determined. Figure 8 shows a representation of the 
appearance of the cells under the fluorescent microscope following treatment and staining. 
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Figure 8: Composite images of HAP1 cells from green and blue channels on the fluorescence 
microscope, following a one-hour treatment with 500 µM BPA. Cell lines shown are (A) Wild 
type, (B) S51A, (C) ∆PKR, (D) ∆HRI, (E) ∆PERK, (F) ∆GCN2. Nuclei appear blue, while stress 
granule proteins (G3BP) are green. 
 
The results of the acute exposure assay can be seen in Figure 9 below. The wild type 
HAP1 cells, the intended negative control, showed an average rate of stress granule formation of 
39.9%. The S51A cells were used as the positive control and showed a low average percentage 
of stress granule formation, 3.6%. The four remaining cell lines of different kinase knockouts 
had highly variable percentages of cells form stress granules - ∆PERK cells averaged the lowest 
of the four with 26.9%, ∆HRI cells averaged 47.8%, ∆GCN2 cells averaged 50.0%, and the 
∆PKR cells averaged 57.1%. Additionally, although three separate trials of this assay were 
performed, the percentage of stress granules formed in each trial was highly variable, even with 
WT and S51A cells. 
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Figure 9: Stress granule formation in response to acute exposure of HAP1 cell lines to BPA. 
Cells were treated with 500 µM solutions of BPA for 1 hour. Error bars represent standard error. 
(n=3) 
 
  
18 
Discussion 
 
U2OS-DS Acute Exposure Assay and Western Blots 
When observing U2OS-DS cells overall, BPA and BPF both produced stress granules 
under acute exposure, while BPS did not. Of the two bisphenols, BPA treatments resulted in 
significantly more stress, producing the highest level of stress granule formation observed. These 
findings corroborate an earlier study that demonstrated that both BPA and BPF, but not BPS, 
cause significant stress granule formation (Salerno et al. 2016). 
Analysis of the mechanism of stress granule formation in U2OS-DS cells was completed 
using Western blots performed on samples taken following acute exposure assays. Band 
intensities in a blot stained for phosphorylated eIF2α allow determination of the intensity of the 
phosphorylation state and stress granule formation response. The high rate of formation of stress 
granules observed in BPA- and BPF-treated U2OS-DS cells correlates to the blot bands 
indicating high proportions of phosphorylated eIF2α. The mechanism of stress granule formation 
in response to BPA and BPF stress appears to be eIF2α phosphorylation, which prevents 
translation initiation. Relative intensity of the bands for each treatment correlated with observed 
rates of stress granule formation. 
Despite the low levels of SG formation observed in BPS, and the variability seen in the 
BPF trials, the risks that these bisphenols possess cannot be ruled out. The experiments used 
uniform concentrations of the bisphenol solutions, which may differ from the actual exposure 
level of bisphenols in daily life. Our findings suggest that even the alternative bisphenols may be 
harmful to health as, like BPA, they also appear capable of triggering the cellular stress response 
via the same pathway. Further investigation into the pathways triggered by the bisphenols may 
continue to elucidate the specific health impacts of these compounds, while the development of 
non-bisphenol BPA alternatives may reduce the risks of widespread bisphenol usage.  
 
HAP1 Acute Exposure Assay 
Following identification of the mechanism of stress granule formation as eIF2α 
phosphorylation, the following assay aimed to identify the kinase responsible for the 
phosphorylation event. PKR-like ER kinase (PERK) knockout cell lines exhibited the lowest 
rates of stress granule formation of the four knockouts (26.9%), and was the only knockout cell 
line that had a significant reduction in SG formation compared to the WT cells. This suggests 
that PERK may be playing the largest role in the phosphorylation of eIF2α that causes stress 
granules. PERK has been associated with responses to endoplasmic reticulum stress, though 
BPA is known to operate through an oxidative stress pathway (Rezg et al. 2014).  
Compared to the U2OS-DS cell line, highly variable rates of stress granule formation 
were observed in each of the six HAP1 cell line, both in kinase knockouts and controls (WT and 
S51A). In the four HAP1 knockouts the stress granule formation rates were between 26.9% 
(∆PERK) and 57.1% (∆PKR). This suggests that a combination of kinases were acting to 
phosphorylate eIF2α in cells under BPA treatment. This could be indicative of the complex 
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mechanism of cellular stress response to BPA in general, or be an aspect of HAP1 cells alone. 
Different cell types do not have identical response to BPA; for instance, the T47D cells showed 
overall lower stress granule formation rates in comparison to U2OS-DS cells at identical 
concentrations. WT HAP1 cells, which were expected to serve as the positive control, did not 
exhibit consistent or high rates of stress granule formation. A BPA, arsenite, and methanol 
chronic exposure assay of WT HAP1 cells could determine baseline rates of stress granule 
formation in treated cells. 
When the HAP1 cell lines were examined, the ∆PERK trials were the only ones showing 
considerable reduction in SG formation compared to WT. This indicates that PERK (usually 
active in endoplasmic reticulum stress) was important in SG formation triggered by the 
bisphenols treatment, while it remains unclear if the other kinases may also play a role in this 
process. The finding that the kinase knockout cell lines such as ∆PKR, ∆GCN2, and ∆HRI 
appeared to produce more SG’s than the WT line is also worth further investigation. This may 
indicate that the HAP1 cells have an inherent difference in their ability to form SGs, or the 
phenomenon may be due to chance. An analysis of significance may elucidate this. Future 
studies could focus on the WT HAP1 cells, and establish a reliable baseline for comparison with 
the kinase knockouts. 
 
T47D Acute Exposure Assay 
Since bisphenols have been shown to have estrogenic effects, this study also investigated 
whether a cell line that contains estrogen receptors would respond differently to the bisphenols in 
terms of stress granule formation than the U2OS-DS cell line, which does not have estrogen 
receptors. The T47D cell line, which has the estrogen receptor α (ERα), was used for this 
purpose. The comparison of the acute exposure assay results for the two cell lines identifies some 
slight differences in the percentage of cells expressing stress granules following treatment with 
the bisphenols. Unlike in the U2OS-DS cells, where BPA caused nearly 100% of cells to form 
stress granules, only around 52% of the T47D cells showed stress granules after BPA treatment. 
Additionally, while only around 11% of BPF-treated U2OS-DS cells formed stress granules, this 
number was increased to 31% in T47D cells. A comparably low percentage of cells treated with 
BPS formed stress granules in both cell lines. Due to the variability of the cell counts between 
trials, particularly with respect to BPA and BPF, four trials instead of the typical three were 
completed. This variability could be a result of the presence of hormone receptors in T47D cells 
- it is likely a result of the endocrine disrupting effects of bisphenols because this variability was 
not observed in the positive and negative controls. Hormone receptors affect cell growth and 
metabolism, and even slightly varied metabolic rates could yield vastly different responses to 
stress in cells. More exploration may be necessary to clarify the variability of the effects of the 
two bisphenols in this cell line. 
The T47D trials gave slightly different results compared to the U2OS-DS trials. The 
apparent lower number of SGs in BPA trials and higher number in BPF trials may suggest 
different sensitivity levels to the two bisphenols, which may be related to the presence of the 
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estrogen receptor in this cell line. However, due to the greater variability seen in the BPF trials, it 
is ambiguous whether the T47D cell are indeed more sensitive to BPF. There is also a possibility 
that the difference in T47D and U2OS-DS trials is not related to the estrogen receptor, but to 
other characteristics of the cell line. This should be explored further using other estrogen 
receptor-positive cell lines. 
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